Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 13, 2002

View Archived Issues

Efficacy and safety of glucagon antagonist demonstrated in early clinical trial

Spotlight on tPA and stroke at ISC

Repligen highlights the progress of its two lead programs

Tumor-targeting polymer conjugate will be codeveloped by Tanabe and Menarini

Late administration of NO donor improves outcome in a rat stroke model

MMP inhibitor does not improve the arterial response to angioplasty and stenting in primates

Vical reviews pipeline progress in 2001

Xenical approved in Canada for use in type 2 diabetics

Launch of delayed-release oral suspension formulation of Prevacid

Approvable letter issued by FDA for Remodulin in pulmonary arterial hypertension

Stressgen validates targeting HspE7 at genital warts market

Roche and Vernalis enter R&D agreement for antiobesity drugs

Estramustine analogues have a promising preclinical profile of antitumor activity

Roche and deCODE enter new drug development alliance

Adenosine derivatives claimed by Pfizer for use in inflammatory respiratory diseases

Yamanouchi synthesizes macrocyclic antitumor agents

Glycolipid derivatives claimed for use as antitumor agents and immunostimulants

Antifungal compound EM-F2300A isolated by Mercian and Eisai

Mutations in optineurin responsible for adult-onset primary open-angle glaucoma

Peptide compounds with fungal adhesion-inhibitory activity

Aurora2 kinase inhibitors patented by AstraZeneca

The novel protein fibrocystin found to be encoded by a mutated gene in ARPKD

Fibrolase derivative under joint development by Hyseq and Amgen as thrombolytic

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...